Cargando…

Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators

Acute intermittent porphyria (AIP) is an autosomal dominant inherited disease with low clinical penetrance, caused by mutations in the hydroxymethylbilane synthase (HMBS) gene, which encodes the third enzyme in the haem biosynthesis pathway. In susceptible HMBS mutation carriers, triggering factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bustad, Helene J., Kallio, Juha P., Vorland, Marta, Fiorentino, Valeria, Sandberg, Sverre, Schmitt, Caroline, Aarsand, Aasne K., Martinez, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827610/ https://www.ncbi.nlm.nih.gov/pubmed/33445488 http://dx.doi.org/10.3390/ijms22020675

Ejemplares similares

A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
por: Bustad, Helene J., et al.
Publicado: (2020)

Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function
por: Christie, Marthe S., et al.
Publicado: (2022)

Self-efficacy and self-management strategies in acute intermittent porphyria
por: Hammersland, Marte H., et al.
Publicado: (2019)

Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria
por: Bustad, Helene J., et al.
Publicado: (2013)

Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study
por: Tollånes, Mette Christophersen, et al.
Publicado: (2010)

Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2020)

Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2019)

Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis
por: Alfadhel, Majid, et al.
Publicado: (2014)

Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers
por: Lin, Chia-Ni, et al.
Publicado: (2021)

Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study
por: Andersen, Janice, et al.
Publicado: (2020)

Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2022)

Correction: Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2022)

HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review
por: Li, Shuang, et al.
Publicado: (2023)

Acute intermittent porphyria: prevalence of pathogenic HMBS variants in China, and epidemiological survey in Hebei Province, China
por: Ma, Liyan, et al.
Publicado: (2022)

Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services
por: Tollånes, Mette C, et al.
Publicado: (2012)

A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome
por: Yang, Yang, et al.
Publicado: (2020)

A novel mutation c.457C > T p.Q153 in the HMBS gene in a Mexican woman with acute intermittent porphyria
por: Malagon‐Rangel, Jose, et al.
Publicado: (2023)

Genetic analysis of acute intermittent porphyria caused by novel classical splicing variant in the insertion region of 29-residue specific to human HMBS protein
por: Liang, Lei, et al.
Publicado: (2023)

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation
por: van Loggerenberg, Warren, et al.
Publicado: (2023)

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation
por: van Loggerenberg, Warren, et al.
Publicado: (2023)

Whole Exome Sequencing Identified a Novel Heterozygous Mutation in HMBS Gene in a Chinese Patient With Acute Intermittent Porphyria With Rare Type of Mild Anemia
por: Zheng, Yongjiang, et al.
Publicado: (2018)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Haplotype Analysis of Norwegian and Swedish Patients with Acute Intermittent Porphyria (AIP): Extreme Haplotype Heterogeneity for the Mutation R116W
por: Tjensvoll, Kjersti, et al.
Publicado: (2003)

Feigning Acute Intermittent Porphyria
por: Elkhatib, Rania, et al.
Publicado: (2014)

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report
por: Guida, Claudio Carmine, et al.
Publicado: (2023)

An overview of the cutaneous porphyrias
por: Dawe, Robert
Publicado: (2017)

Cardiac calcification in acute intermittent porphyria
por: Ghatak, Tanmoy, et al.
Publicado: (2011)

Acute Intermittent Porphyria in Argentina: An Update
por: Cerbino, Gabriela Nora, et al.
Publicado: (2015)

Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021)

Liver Transplantation for Acute Intermittent Porphyria
por: Lissing, Mattias, et al.
Publicado: (2021)

Mortality in Pedigrees with Acute Intermittent Porphyria
por: Neeleman, Rochus, et al.
Publicado: (2022)

European Porphyria Network (EPNET) for information, epidemiological data, quality and equity of service
por: Deybach, Jean-Charles, et al.
Publicado: (2010)

Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism
por: Bustad, Helene J., et al.
Publicado: (2021)

An update of clinical management of acute intermittent porphyria
por: Pischik, Elena, et al.
Publicado: (2015)

Acute Intermittent Porphyria: A Diagnostic Challenge
por: Vakili, Rahim, et al.
Publicado: (2016)

Effect of Menstrual Cycle on Acute Intermittent Porphyria
por: Júnior, V. R. Souza, et al.
Publicado: (2017)

Medical and financial burden of acute intermittent porphyria
por: Neeleman, Rochus A., et al.
Publicado: (2018)

Dental and Periodontal Health in Acute Intermittent Porphyria
por: Storjord, Elin, et al.
Publicado: (2022)

Biomarkers that predict attacks of acute intermittent porphyria
por: Takata, Tadayuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fl3co00nlnhqmmsqdlos7r4s1l